Because the increased expression of EpCAM in exosomes has been suggested among patients with certain cancer types, a methodology that differentiates mixtures of exosomes into EpCAM(+) and EpCAM(−) subpopulations is urgently required to develop diagnostic devices that use exosomes. This evidence concerns the gene EPCAM and cancer.